Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|May 22, 2007
Bisphosphonates for breast cancer: questions answered, questions remainingRachel Layman, Karin Olson, Catherine Van PoznakMaturitas|September 29, 2012
The management of osteoporosis in breast cancer survivorsPamela Taxel, Palak Choksi, Catherine Van PoznakClinical Breast Cancer|May 13, 2009
Markers of bone metabolism in women receiving aromatase inhibitors for early-stage breast cancerMyra Barginear, Anne Clotfelter, Catherine Van PoznakBone|November 10, 2020
Pharmacologic management of metastatic bone diseaseEric Schwartz, Zachery Reichert, Catherine Van PoznakCurrent Opinion in Supportive and Palliative Care|July 27, 2010
Updates on osteonecrosis of the jawJunro Yamashita, Laurie K McCauley, Catherine Van PoznakCurrent Osteoporosis Reports|July 26, 2015
Adjuvant Endocrine Therapy and Bone Health in Breast CancerGregory A Clines, Palak Choksi, Catherine Van PoznakJournal of the Endocrine Society|June 27, 2018
Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate CancerPamela Taxel, Erika Faircloth, Sana Idrees, et al.Seminars in Oncology|November 26, 2008
Cancer therapy and osteoporosis: approach to evaluation and managementG J van Londen, Pamela Taxel, Catherine Van PoznakBreast Cancer : Basic and Clinical Research|January 24, 2014
Oncotype dx results in multiple primary breast cancersMichael J Toole, Kelley M Kidwell, Catherine Van PoznakOncology (Williston Park, N.Y.)|November 19, 2002
HER2 testing and correlation with efficacy of trastuzumab therapyMonica Fornier, Mauro Risio, Catherine Van Poznak, et al.Pageof 9